Ventripoint

Ventripoint Diagnostics (#TSXV: $VPT | #OTC: $VPTDF) is an industry leader in AI applications for echocardiography that develops smart tools for heart health.

[Ventripoint @ventripointIR]

A McKinsey & Co. analysis points out that digital health innovators can help improve patient lives, make healthcare systems more efficient, and make a positive economic impact.

Discover how $VPT pursues health & economy goals: https://t.co/IQoeNBA21y

#TSX #TSXV $VPT #OTC $VPTDF

[Ventripoint @ventripointIR]

Vendor-neutrality is a core feature of the VMS+ system and works with echo images generated from any ultrasound system, irrespective of make or model. This enables VMS+ use in diverse healthcare settings.

Explore more: https://t.co/ld5txpQlTw

#TSX #TSXV $VPT #OTC $VPTDF

[Ventripoint @ventripointIR]

The $VPT strategy works with the help of trusted distributors including:

• 970 Equipment
• Meditek Lifesciences
• Coviix Biosciences
• Alpha Surgical Solutions
• Cardiologic Limited
• Angiopro GmbH

See the full list: https://t.co/5YKP7uGKLc

#TSX #TSXV #OTC $VPTDF

[Ventripoint @ventripointIR]

The VMS+ 3.0 is ready for quick integration into clinical infrastructure, with minimal setup and intuitive software design. With few hardware requirements, our designs are suitable for underserved markets.

Find out more: https://t.co/ld5txpQlTw

#TSX #TSXV $VPT #OTC $VPTDF

[Ventripoint @ventripointIR]

The VMS+ is powered by our proprietary Knowledge-Based Reconstruction algorithm. This algorithm recreates the shape of a patient’s heart in 3D through captured 2D ultrasound images.

Explore $VPT innovation: https://t.co/ld5txpQlTw

#TSX #TSXV #OTC $VPTDF

[Ventripoint @ventripointIR]

Our VMS+ line is adapted for innovation:

🩺 Fast, accurate, and reproducible measurements
🩺 3D cardiac imaging
🩺 Insights into the heart's structure & functions
🩺 Innovative sensor tracking

See our groundbreaking approach: https://t.co/ld5txpQlTw

#TSX #TSXV $VPT #OTC $VPTDF

[Ventripoint @ventripointIR]

The WHO's Global Strategy on Digital Health recognizes its potential to boost the efficiency and cost-effectiveness of care and bring about new business models for services.

Discover the unique advantage of $VPT innovation: https://t.co/BX8Gzl1bme

#TSX #TSXV #OTC $VPTDF

[Ventripoint @ventripointIR]

Cardiac imaging plays a pivotal role in the diagnosis and surveillance of patients with a variety of heart conditions, especially those awaiting pulmonary valve replacement.

Read more on $VPT's extensive case studies: https://t.co/tKxzfrWzcC

#TSX #TSXV #OTC $VPTDF

[Ventripoint @ventripointIR]

The FDA's Digital Health Innovation Action Plan notes the potential of digital health technologies for more efficient clinical practice and highly accessible digital health products.

Learn how $VPT keeps ahead of these innovations: https://t.co/fT0bKlXYgP

#TSX #TSXV #OTC $VPTDF

[Ventripoint @ventripointIR]

The software as a medical device market may hit $86.4 billion by 2027 with a compound annual growth rate of 21.9%, according to an analysis by The Insight Partners.

Know how Ventripoint Diagnostics fits into this: https://t.co/VzzgkbGSkH

#TSX #TSXV $VPT #OTC $VPTDF

[Ventripoint @ventripointIR]

$VPT's sales & marketing push included:

• Key hires to cover US, UK & Europe markets
• Partnerships with 11 distributors; bringing the sales team to 33 representatives
• Attending & sponsoring 12 medical conferences

Learn more: https://t.co/fT0bKlXYgP

#TSX #TSXV #OTC $VPTDF

[Ventripoint @ventripointIR]

Ease of use and customer satisfaction are our priorities. Ventripoint Diagnostics make sure that support documentation is easily available on our website.

See how you can be a part of our company strategy: https://t.co/fT0bKlXYgP

#TSX #TSXV $VPT #OTC $VPTDF

[Ventripoint @ventripointIR]

We are moving forward with our mission. The Ventripoint Diagnostics team is focused on driving revenues through tactical growth in the company's salesforce, channel partners and trial teams.

Read our latest update: https://t.co/SpNyAWUwj5

#TSX #TSXV $VPT #OTC $VPTDF

[Ventripoint @ventripointIR]

Software as a Medical Device or SaMD represents the next generation of medical technology products. Ventripoint Diagnostics' VMS+ software line is part of this apex of innovation.

Discover more: https://t.co/ld5txpQlTw

#TSX #TSXV $VPT #OTC $VPTDF

[Ventripoint @ventripointIR]

Healthcare delivery systems are shifting from patient-centric to patient-led. These systems call for deep integration of people, services, software & hardware.
$VPT is laying the groundwork for patient-led cardiac health.

See more: https://t.co/BX8Gzl1bme

#TSX #TSXV #OTC $VPTDF

[Ventripoint @ventripointIR]

A McKinsey & Co. analysis notes that portable diagnostics and medical devices may just clear the hurdle of costly diagnostic equipment. $VPT is creating a future for accessible diagnostics through the VMS+ system.

Visit us: https://t.co/BX8Gzl1bme

#TSX #TSXV #OTC $VPTDF

[Ventripoint @ventripointIR]

Ventripoint Diagnostics Ltd. announces its sponsorship of the 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology to be held on April 26–29, 2023 in Dublin, Ireland.

Get the full details: https://t.co/BTWF6UTIAb

#TSX #TSXV $VPT #OTC $VPTDF

[Ventripoint @ventripointIR]

Ventripoint was privileged to have attended the 89th Annual Conference of the German Society for Cardiology – Heart and Circulatory Research where we showcased the value of the VMS+ 3.0.

Learn more about the VMS+ 3.0: https://t.co/V2MkLpfU1A

#TSX #TSXV $VPT #OTC $VPTDF

[Ventripoint @ventripointIR]

"The average completion rate was 97.8% for the entire process and the average error-free rate was 81.7%... The VMS+ scored extremely high for ease-of-use and confidence in using the system..."

View the full study: https://t.co/hd7j4Hwlm9

#TSX #TSXV $VPT #OTC $VPTDF

[Ventripoint @ventripointIR]

Research by The Insight Partners reveals three main applications for software as a medical device (SaMD):

⚕️ Screening and diagnostics
⚕️ Monitoring and alerting
⚕️ Disease management

Discover how $VPT fits into this trend: https://t.co/VzzgkbGSkH

#TSX #TSXV #OTC $VPTDF